Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone.

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

Here’s what you’ll learn when you read this story: Treating Alzheimer’s requires a multi-faceted approach that can target various mechanisms behind this pernicious neurodegenerative disease. In a new ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a short protein called P3, the ‘neglected cousin’ of amyloid beta ...

One current research avenue is to look at currently-approved medications that are used for other diseases, an approach that is called drug repurposing. A new study has identified two cancer ...

Over seven million Americans are living with Alzheimer's disease (AD), and the heartbreaking day-to-day battle with the effects of cognitive decline. According to the Alzheimer's Association, the ...

Persistent inflammation in the gut, lungs and skin might lead to Alzheimer's disease, but lifestyle choices - from getting ...